Skip to main content
Premium Trial:

Request an Annual Quote

Nuvelo Posts Miniscule Revenue, Doubled Losses in Q2

NEW YORK, July 31 - Nuvelo reported  a severe falloff in second-quarter revenue atop decreased R&D spending and a widened net loss.


Total receipts for the period ended June 30 shrank to $394,000 from $6.7 million over the same period one year ago. The company attributed the fall to the completion of a gene-discovery collaboration with BASF Plant Science.


Nuvelo, the product of a merger by Hyseq and Variagenics, said second-quarter R&D spending also fell, to $7.3 million from $10.7 million year over year.


Net loss in the quarter more than doubled to $16.3 million, or $.26 per share, from $8 million, or $37 per share, during the second quarter 2002. Nuvelo attributed the loss to a one-time $5 million charge related to the termination of a lease with one of its facilities.


Ted Love, president and CEO of Nuvelo, said the firm is continuing to "monetize" the none-core assets acquired from Variagenics. It was not clear what assets have been sold, or what others have been put on the block. A Nuvelo spokesman did not immediately return a telephone call seeking comment.


Nuvelo said it had around $26.6 million in cash, cash equivalents, and short-term investments as of June 30.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.